)
Niagen Bioscience (NAGE) investor relations material
Niagen Bioscience Fireside chat summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Introduction and agenda
Discussion focused on the strategic expansion into pharmaceutical development, particularly the NB4168 drug program targeting accelerated aging and rare genetic diseases.
Audience Q&A was included, with questions submitted live and in advance.
Background and experience of the speaker
The team includes leading NAD researchers, such as Vil Bohr and Dr. Charles Brenner, with extensive experience in orphan diseases and anti-aging research.
Additional world-class scientific advisors are being added to strengthen expertise.
Current industry trends
Growing awareness and demand for NAD-related products, with steady growth in core supplement and ingredient businesses.
Expansion into telehealth and topical NAD products, alongside pharmaceutical development.
- Advancing NB4168 for rare genetic diseases with strong clinical data and premium market potential.NAGE
Corporate presentation15 Jul 2026 - Record revenue, profitability, and cash flow set the stage for double-digit growth in 2025.NAGE
Q4 20249 Jul 2026 - Patented NAD+ products, strong clinical data, and expanding verticals drive robust growth.NAGE
Corporate presentation8 Jul 2026 - Registering up to $125M in securities, including $50M at-the-market, to fund growth and operations.NAGE
Registration filing29 Jun 2026 - Strong growth in NAD-based health products, injectables, and skincare, with expanding partnerships.NAGE
16th Annual East Coast IDEAS Conference12 Jun 2026 - Q1 2026 net sales rose 3% to $31.5M, net income $6.3M, $4.8M segment sale gain, $66.5M cash.NAGE
Q1 20266 May 2026 - Annual meeting to vote on directors, auditor, and executive pay, with online proxy access.NAGE
Proxy filing29 Apr 2026 - Board recommends approval of all proposals, emphasizing governance and performance-linked pay.NAGE
Proxy filing29 Apr 2026 - Double-digit growth, strong margins, and clinical validation drive expansion in NAD+ wellness.NAGE
Corporate presentation4 Mar 2026
Next Niagen Bioscience earnings date
Next Niagen Bioscience earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)